EIKO Lifesciences Fair Value
EIKO Lifesciences (EIKO) average fair value is ₹73.97 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹44.16 (+67.5%), fair value range ₹13.77–₹235.25. Browse EIKO complete financial statements for revenue, profit, balance sheet and cash flow data.
Fair Value Analysis Export
EIKO Fair Value vs Current Price — Valuation Summary
EIKO average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Read EIKO dividend track record for the complete payout history and dividend yield track record.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
EIKO Fair Value Analysis — Data Sources & Coverage
EIKO Lifesciences financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit EIKO Lifesciences share price chart.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
EIKO vs Chemicals Sector Peers — P/E, P/B & Market Cap
EIKO Lifesciences P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Mehul Colours | MEHUL | 10.38 | 1.31 | ₹57 |
| National Fertilizers | NFL | 9.35 | 1.2 | ₹3,360 |
| AG Ventures | AGVENTURES | 5.11 | 0.47 | ₹127 |
| Epigral | EPIGRAL | 10.84 | 1.74 | ₹3,648 |
| PB Global | PBGLOBAL | -0.03 | 0.02 | ₹0 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.